Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Shares Issued (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Shares Issued data on record, last reported at $1.0 million in Q2 2025.

  • For Q2 2025, Shares Issued changed N/A year-over-year to $1.0 million; the TTM value through Sep 2025 reached $5.0 million, up 99.84%, while the annual FY2024 figure was $4.9 million, 1206.67% up from the prior year.
  • Shares Issued reached $1.0 million in Q2 2025 per SNTI's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $225.4 million in Q4 2021 and bottomed at $67000.0 in Q4 2023.
  • Average Shares Issued over 5 years is $22.5 million, with a median of $1.5 million recorded in 2025.
  • Peak YoY movement for Shares Issued: plummeted 94.68% in 2022, then skyrocketed 3586.57% in 2024.
  • A 5-year view of Shares Issued shows it stood at $225.4 million in 2021, then plummeted by 99.83% to $381000.0 in 2022, then tumbled by 82.41% to $67000.0 in 2023, then surged by 3586.57% to $2.5 million in 2024, then crashed by 59.11% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $1.0 million in Q2 2025, $1.5 million in Q1 2025, and $2.5 million in Q4 2024.